Campbell Soup Co. (CPB) Stock Price Today
Aura AI Summary
Key Stats
- $6.81BMarket Cap
- 4,465,767Volume
- Consumer StaplesSector
- $31.6652W High
- $18.9052W Low
- 101 DaysTypical Hold Time
- $13.86BEnterprise Value
- 4.39%Div Yield
- -Trading Activity
Track Campbell Soup Co. (CPB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Campbell Soup Co. has traded between a low of $18.9 and a high of $31.66, highlighting its annual price range. Buy and sell Campbell Soup Co. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Campbell Soup Co.
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Most Recent News
All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects
Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...

IDEAYA nominates IDE101, a novel dual CDK inhibitor targeting CDKN2A-deficient tumors, aiming for FDA filing in H1 2027.
IDEAYA Biosciences announced IDE101 as a new development candidate designed to treat tumors with CDKN2A deficiency, common in 10-15% of solid tumors including 70% of pancreatic cancers. IDE101 is a first-in-class dual cyclin-dependent kinase inhibito...

Nvidia earnings, Anthropic IPO, and GTA 6 launch mark a pivotal week for AI and gaming sectors.
Nvidia reports earnings with new CFO Colette Kress amid concerns over Jensen Huang's departure and Singapore revenue scrutiny. Expectations are $2.47 EPS and $108.73 billion revenue, with mixed analyst views on AI adoption risks and stock potential. ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.